Published in Res Pharm Sci on July 01, 2012
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res (1988) 17.88
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol (2008) 8.70
Aromatase inhibitors in breast cancer. N Engl J Med (2003) 5.01
The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol (2006) 1.94
Risk factors with breast cancer among women in Delhi. Indian J Cancer (2009) 1.22
Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer. Semin Oncol (2003) 1.08
Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay. Mutagenesis (2002) 1.06
Aromatase inhibitors: past, present and future in breast cancer therapy. Med Oncol (2007) 1.02
Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection. Onco Targets Ther (2010) 0.90
New developments in the treatment of postmenopausal breast cancer. Trends Endocrinol Metab (2005) 0.88
Oestrogens induce G(1) arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival. Mutagenesis (2002) 0.87
Reduction in hormone replacement therapy use and declining breast cancer incidence in the Belgian province of Limburg. Breast Cancer Res Treat (2009) 0.83
1-[(Benzofuran-2-yl)phenylmethyl]-triazoles and -tetrazoles - potent competitive inhibitors of aromatase. Bioorg Med Chem Lett (1999) 0.83
Substituted 1-[benzofuran-2-yl)-phenylmethyl]-imidazoles as potent inhibitors of aromatase in vitro and in female rats in vivo. J Steroid Biochem Mol Biol (1993) 0.82
Enantioselectivity of some 1-[(benzofuran-2-yl) phenylmethyl] imidazoles as aromatase (P450AROM) inhibitors. J Enzyme Inhib (2001) 0.81
Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development. Mol Cell Endocrinol (2010) 0.81
Synthesis of some new tricyclic 4(3H)-quinazolinone derivatives. Res Pharm Sci (2011) 0.88
Baseline evaluation of hand hygiene compliance in three major hospitals, Isfahan, Iran. J Hosp Infect (2013) 0.85
Antibacterial, antifungal and cytotoxic evaluation of some new quinazolinone derivatives. Res Pharm Sci (2012) 0.81
In vitro anti-bacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res Pharm Sci (2013) 0.80
Quantitative evaluation of DNMT3B promoter methylation in breast cancer patients using differential high resolution melting analysis. Res Pharm Sci (2013) 0.78
Synthesis of some new 2,3-disubstituted-4(3H)quinazolinone derivatives. Res Pharm Sci (2012) 0.78
Mutating Asn-666 to Glu in the O-helix region of the taq DNA polymerase gene. Res Pharm Sci (2010) 0.75